Niu Technologies And NeuroMetrix On The List Of Winners And Losers Of Tuesday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today‚Äôs list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are Niu Technologies, iRobot, and Inovio Pharmaceuticals.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Niu Technologies (NIU) 3.96 2.86% 2023-07-25 07:14:23
2 iRobot (IRBT) 47.97 2.28% 2023-07-25 04:10:40
3 Inovio Pharmaceuticals (INO) 0.51 2.06% 2023-07-25 04:10:31
4 Alibaba (BABA) 97.81 1.52% 2023-07-25 04:38:12
5 MicroVision (MVIS) 3.71 1.37% 2023-07-25 04:11:16
6 Canopy Growth (CGC) 0.40 1.34% 2023-07-25 07:21:20
7 DocuSign (DOCU) 52.50 1.31% 2023-07-25 07:13:48
8 UBS Group (UBS) 21.69 1.26% 2023-07-25 04:45:52
9 Regions Financial Corporation (RF) 20.22 1.1% 2023-07-25 07:20:03
10 Ecopetrol S.A. (EC) 11.37 1.07% 2023-07-25 07:17:39

The three biggest losers today are NeuroMetrix, Teva Pharmaceutical, and American Public Education.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 NeuroMetrix (NURO) 0.96 -1.93% 2023-07-25 04:35:59
2 Teva Pharmaceutical (TEVA) 8.49 -1.74% 2023-07-25 04:45:22
3 American Public Education (APEI) 4.71 -1.26% 2023-07-25 07:07:51
4 FibroGen (FGEN) 2.07 -0.96% 2023-07-25 07:09:27
5 Telefonica (TEF) 4.10 -0.73% 2023-07-25 04:45:18
6 Essex Property Trust (ESS) 243.00 -0.57% 2023-07-25 04:17:56
7 Illumina (ILMN) 187.00 -0.57% 2023-07-25 07:10:19
8 Cronos Group (CRON) 1.84 -0.54% 2023-07-25 07:13:39
9 iShares MBS ETF (MBB) 92.61 -0.48% 2023-07-25 04:14:18
10 CNH Industrial (CNHI) 15.57 -0.39% 2023-07-25 07:17:03

Premarket Winners today

1. Niu Technologies (NIU) – Premarket: 2.86%

Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers RQi, NQi, MQi, SQi, UQi, and Gova series electric scooters and motorcycles; KQi series one kick-scooters; BQi series e-bikes; and Niu Aero Sports Bicycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, smart check, and smart services, as well as NIU cover, which provides insurance services. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Niu Technologies jumping 3.22% to $3.85 on Tuesday while NASDAQ jumped 0.19% to $14,058.87.

Earnings Per Share

As for profitability, Niu Technologies has a trailing twelve months EPS of $-0.14.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.41%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Niu Technologies’s EBITDA is -4.41.

More news about Niu Technologies.

2. iRobot (IRBT) – Premarket: 2.28%

iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides H1 Handheld Vacuum, a portable vacuum; H1 Handheld Vacuum accessories comprising filters, chargers, batteries, and an extension kit that converts the H1 Handheld Vacuum into a stick vacuum; air purifiers under the Aeris brand; Root robots to help children learn how to code; and Create 3, a mobile robot platform that offers an opportunity for educators, developers, and high-school and college students to program behaviors, sounds, movements, and add additional electronics, as well as sells filters and fabric covers. The company sells its products through chain stores and other national retailers, distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts.

NASDAQ ended the session with iRobot sliding 1.11% to $46.90 on Tuesday, after four successive sessions in a row of losses. NASDAQ jumped 0.19% to $14,058.87, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, iRobot has a trailing twelve months EPS of $-12.57.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.8%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

iRobot’s EBITDA is -15.25.

Volume

Today’s last reported volume for iRobot is 195616 which is 65.18% below its average volume of 561901.

Sales Growth

iRobot’s sales growth is negative 11% for the present quarter and negative 7.1% for the next.

More news about iRobot.

3. Inovio Pharmaceuticals (INO) – Premarket: 2.06%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals dropping 3.25% to $0.50 on Tuesday while NASDAQ rose 0.19% to $14,058.87.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-1.04.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.

Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $0.50 at 08:34 EST, way below its 52-week high of $2.82 and way higher than its 52-week low of $0.38.

Moving Average

Inovio Pharmaceuticals’s value is way below its 50-day moving average of $0.56 and way below its 200-day moving average of $1.27.

Volatility

Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.12%, a positive 0.70%, and a positive 4.27%.

Inovio Pharmaceuticals’s highest amplitude of average volatility was 4.51% (last week), 5.80% (last month), and 4.27% (last quarter).

More news about Inovio Pharmaceuticals.

4. Alibaba (BABA) – Premarket: 1.52%

Alibaba Group Holding Limited, through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses to engage with their users and customers in the People's Republic of China and internationally. The company operates through seven segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others. It operates Taobao Marketplace, a social commerce platform; Tmall, a third-party online and mobile commerce platform for brands and retailers; Alimama, a monetization platform; 1688.com and Alibaba.com, which are online wholesale marketplaces; AliExpress, a retail marketplace; Lazada, Trendyol, and Daraz that are e-commerce platforms; Freshippo, a self-operated retail chain; and Tmall Global, an import e-commerce platform. The company also operates Taoxianda, an online-offline integration service for FMCG brands and third-party grocery retail partners; Cainiao Network logistic services platform; Ele.me, an on-demand delivery and local services platform; Koubei, a restaurant and local services guide platform; and Fliggy, an online travel platform. In addition, it offers pay-for-performance, in-feed, and display marketing services; and Taobao Ad Network and Exchange, a real-time online bidding marketing exchange. Further, the company provides elastic computing, storage, network, security, database and big data, and IoT services. Additionally, it operates Youku, an online video platform; Alibaba Pictures and other content platforms that provide online videos, films, live events, news feeds, literature, music, and others; Amap, a mobile digital map, navigation, and real-time traffic information app; DingTalk, a business efficiency mobile app; and Tmall Genie smart speaker. The company was incorporated in 1999 and is based in Hangzhou, the People's Republic of China.

NYSE ended the session with Alibaba rising 4.54% to $96.35 on Tuesday while NYSE rose 0.49% to $16,369.14.

Earnings Per Share

As for profitability, Alibaba has a trailing twelve months EPS of $3.87.

PE Ratio

Alibaba has a trailing twelve months price to earnings ratio of 24.9. Meaning, the purchaser of the share is investing $24.9 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.95%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Alibaba’s EBITDA is 7.11.

Previous days news about Alibaba

  • Alibaba says it won't reduce its stake in ant group. According to MarketWatch on Monday, 24 July, "Chinese e-commerce giant Alibaba says it does not plan to sell any shares in its one-third shareholding in financial technology company Ant Group because it wants to retain its stake in an "important strategic partner.", "Given that Ant Group continues to be an important strategic partner to Alibaba Group’s various businesses, Alibaba Group has decided that it will not sell any shares to Ant Group under the proposed share repurchase, so as to maintain its shareholding in Ant Group,"Alibabasaid in the filing."

More news about Alibaba.

5. MicroVision (MVIS) – Premarket: 1.37%

MicroVision, Inc. develops and sells lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module supporting AR headsets; interactive display solutions for the smart speakers market; and Consumer Lidar used in smart home systems. In addition, it develops 1st Generation LRL module. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.

NASDAQ ended the session with MicroVision dropping 2.92% to $3.66 on Tuesday while NASDAQ rose 0.19% to $14,058.87.

Earnings Per Share

As for profitability, MicroVision has a trailing twelve months EPS of $-0.35.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -62.05%.

Sales Growth

MicroVision’s sales growth for the current quarter is 154.8%.

More news about MicroVision.

6. Canopy Growth (CGC) – Premarket: 1.34%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth jumping 1.63% to $0.39 on Tuesday while NASDAQ rose 0.19% to $14,058.87.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-5.34.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.11%.

More news about Canopy Growth.

7. DocuSign (DOCU) – Premarket: 1.31%

DocuSign, Inc. provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce. It also provides Identify, a signer-identification option for checking government-issued IDs; Standards-Based Signatures, which support signatures that involve digital certificates; and Monitor that uses advanced analytics to track DocuSign eSignature web, mobile, and API account. In addition, the company offers Rooms for Real Estate that provides a way for brokers and agents to manage the entire real estate transaction digitally; DocuSign Federal and DocuSign CLM are FedRAMP, an authorized version of DocuSign eSignature for U.S. federal government agencies; and life sciences modules that support compliance with the electronic signature practices. The company sells its products through direct and partner-assisted sales, and web-based self-service purchasing. The company was incorporated in 2003 and is headquartered in San Francisco, California.

NASDAQ ended the session with DocuSign sliding 0.46% to $51.82 on Tuesday while NASDAQ rose 0.19% to $14,058.87.

Earnings Per Share

As for profitability, DocuSign has a trailing twelve months EPS of $-0.35.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.66%.

Volatility

DocuSign’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.98%, a positive 0.17%, and a positive 1.66%.

DocuSign’s highest amplitude of average volatility was 1.63% (last week), 1.52% (last month), and 1.66% (last quarter).

Moving Average

DocuSign’s value is below its 50-day moving average of $53.10 and under its 200-day moving average of $53.62.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 50% and 5.3%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

DocuSign’s EBITDA is 3.91.

More news about DocuSign.

8. UBS Group (UBS) – Premarket: 1.26%

UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through four divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, and Investment Bank. The Global Wealth Management division offers investment advice and solutions, and lending solutions. This segment also provides estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. The Personal & Corporate Banking division provides personal banking products and services, such as deposits, cards, and online and mobile banking, as well as lending, investments, and retirement services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, trade and export finance, and global custody solutions, as well as transaction banking solutions for payment and cash management. The Asset Management division offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. The Investment Bank division advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; distribute, trade, finance, and clear cash equities and equity-linked products; and offers clients differentiated content on major financial markets and securities. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is based in Zurich, Switzerland.

NYSE ended the session with UBS Group jumping 0.63% to $21.42 on Tuesday, after four successive sessions in a row of gains. NYSE rose 0.49% to $16,369.14, after five sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, UBS Group has a trailing twelve months EPS of $1.96.

PE Ratio

UBS Group has a trailing twelve months price to earnings ratio of 10.93. Meaning, the purchaser of the share is investing $10.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.27%.

Sales Growth

UBS Group’s sales growth is negative 3% for the ongoing quarter and 33.9% for the next.

More news about UBS Group.

9. Regions Financial Corporation (RF) – Premarket: 1.1%

Regions Financial Corporation, a financial holding company, provides banking and bank-related services to individual and corporate customers. It operates through three segments: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment offers commercial banking services, such as commercial and industrial, commercial real estate, and investor real estate lending; equipment lease financing; deposit products; and securities underwriting and placement, loan syndication and placement, foreign exchange, derivatives, merger and acquisition, and other advisory services. It serves corporate, middle market, and commercial real estate developers and investors. The Consumer Bank segment provides consumer banking products and services related to residential first mortgages, home equity lines and loans, consumer credit cards, and other consumer loans, as well as deposits. The Wealth Management segment offers credit related products, and retirement and savings solutions; and trust and investment management, asset management, and estate planning services to individuals, businesses, governmental institutions, and non-profit entities. It also provides investment and insurance products; low-income housing tax credit corporate fund syndication services; and other specialty financing services. The company was founded in 1971 and is headquartered in Birmingham, Alabama.

NYSE ended the session with Regions Financial Corporation jumping 1.39% to $20.00 on Tuesday, after two successive sessions in a row of gains. NYSE jumped 0.49% to $16,369.14, after five consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Regions Financial Corporation has a trailing twelve months EPS of $2.39.

PE Ratio

Regions Financial Corporation has a trailing twelve months price to earnings ratio of 8.37. Meaning, the purchaser of the share is investing $8.37 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.63%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Aug 30, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 4%.

More news about Regions Financial Corporation.

10. Ecopetrol S.A. (EC) – Premarket: 1.07%

Ecopetrol S.A. operates as an integrated energy company. The company operates through four segments: Exploration and Production; Transport and Logistics; Refining, Petrochemical and Biofuels; and Electric Power Transmission and Toll Roads Concessions. It engages in the exploration and production of oil and gas; transportation of crude oil, motor fuels, fuel oil, and other refined products, including diesel, jet, and biofuels; processing and refining crude oil; distribution of natural gas and LPG; sale of refined and petrochemical products; supplying of electric power transmission services; design, development, construction, operation, and maintenance of road and energy infrastructure projects; and supplying of information technology and telecommunications services. As of December 31, 2022, the company had approximately 9,127 kilometers of crude oil and multi-purpose pipelines. It also produces and commercializes polypropylene resins and compounds, and masterbatches; and offers industrial service sales to customers and specialized management services. It has operations in Colombia, the United States, Asia, Central America and the Caribbean, Europe, and South America. The company was formerly known as Empresa Colombiana de Petróleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was incorporated in 1948 and is headquartered in Bogotá, Colombia.

NYSE ended the session with Ecopetrol S.A. rising 1.51% to $11.25 on Tuesday, after five sequential sessions in a row of gains. NYSE rose 0.49% to $16,369.14, after five successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Ecopetrol S.A. has a trailing twelve months EPS of $3.66.

PE Ratio

Ecopetrol S.A. has a trailing twelve months price to earnings ratio of 3.07. Meaning, the purchaser of the share is investing $3.07 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.9%.

More news about Ecopetrol S.A..

Premarket Losers Today

1. NeuroMetrix (NURO) – Premarket: -1.93%

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

NASDAQ ended the session with NeuroMetrix jumping 2.01% to $0.98 on Tuesday, following the last session’s upward trend. NASDAQ rose 0.19% to $14,058.87, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.76%.

Yearly Top and Bottom Value

NeuroMetrix’s stock is valued at $0.98 at 08:34 EST, way below its 52-week high of $4.73 and way higher than its 52-week low of $0.89.

More news about NeuroMetrix.

2. Teva Pharmaceutical (TEVA) – Premarket: -1.74%

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory, and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

NYSE ended the session with Teva Pharmaceutical jumping 1.47% to $8.64 on Tuesday, after four successive sessions in a row of gains. NYSE jumped 0.49% to $16,369.14, after five successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Teva Pharmaceutical has a trailing twelve months EPS of $-1.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.93%.

Yearly Top and Bottom Value

Teva Pharmaceutical’s stock is valued at $8.64 at 08:34 EST, way under its 52-week high of $11.45 and way above its 52-week low of $7.04.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Teva Pharmaceutical’s EBITDA is 93.61.

More news about Teva Pharmaceutical.

3. American Public Education (APEI) – Premarket: -1.26%

American Public Education, Inc., together with its subsidiaries, provides online and campus-based postsecondary education and career learning. It operates through three segments: American Public University System, Rasmussen University, and Hondros College of Nursing. The company offers 136 degree programs and 115 certificate programs in various fields of study, including nursing, public health, public administration, and business administration. It also provides nursing-and health sciences-focused postsecondary education, diploma in practical nursing, and an associate degree in nursing. The company was incorporated in 1991 and is headquartered in Charles Town, West Virginia.

NASDAQ ended the session with American Public Education dropping 0.21% to $4.77 on Tuesday while NASDAQ rose 0.19% to $14,058.87.

Earnings Per Share

As for profitability, American Public Education has a trailing twelve months EPS of $-6.76.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.91%.

Volatility

American Public Education’s last week, last month’s, and last quarter’s current intraday variation average was 0.61%, 0.33%, and 3.99%.

American Public Education’s highest amplitude of average volatility was 3.79% (last week), 3.13% (last month), and 3.99% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

American Public Education’s EBITDA is 104.34.

More news about American Public Education.

4. FibroGen (FGEN) – Premarket: -0.96%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen sliding 0.71% to $2.09 on Tuesday while NASDAQ jumped 0.19% to $14,058.87.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-2.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -411.93%.

More news about FibroGen.

5. Telefonica (TEF) – Premarket: -0.73%

Telefónica, S.A., together with its subsidiaries, provides telecommunications services in Europe and Latin America. The company's mobile and related services and products comprise mobile voice, value added, mobile data and Internet, wholesale, corporate, roaming, fixed wireless, and trunking and paging services. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone services; local, domestic, and international long-distance and fixed-to-mobile communications; corporate communications; supplementary value-added services; video telephony; intelligent network; and telephony information services, as well as leases and sells handset equipment. The company also provides Internet and broadband multimedia services comprising Internet service provider, portal and network, retail and wholesale broadband access, narrowband switched access, high-speed Internet through fibre to the home, and voice over Internet protocol services. In addition, it offers leased line, virtual private network, fibre optics, web hosting and application, managed hosting, content delivery, outsourcing and consultancy, desktop, and system integration and professional services. Further, the company offers wholesale services for telecommunication operators, including domestic interconnection and international wholesale services; leased lines for other operators; and local loop leasing services, as well as bit stream services, wholesale line rental accesses, and leased ducts for other operators' fiber deployment. Additionally, it provides video/TV services; smart connectivity and services, and consumer IoT products; financial and other payment, security, cloud, advertising, big data, and digital experience services; virtual assistants; and Movistar Home devices. The company was incorporated in 1924 and is headquartered in Madrid, Spain.

NYSE ended the session with Telefonica jumping 0.73% to $4.13 on Tuesday while NYSE jumped 0.49% to $16,369.14.

Earnings Per Share

As for profitability, Telefonica has a trailing twelve months EPS of $0.27.

PE Ratio

Telefonica has a trailing twelve months price to earnings ratio of 15.3. Meaning, the purchaser of the share is investing $15.3 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.13%.

More news about Telefonica.

6. Essex Property Trust (ESS) – Premarket: -0.57%

Essex Property Trust, Inc., an S&P 500 company, is a fully integrated real estate investment trust (REIT) that acquires, develops, redevelops, and manages multifamily residential properties in selected West Coast markets. Essex currently has ownership interests in 251 apartment communities comprising approximately 62,000 apartment homes with an additional property in active development.

NYSE ended the session with Essex Property Trust dropping 0.3% to $244.40 on Tuesday while NYSE jumped 0.49% to $16,369.14.

Earnings Per Share

As for profitability, Essex Property Trust has a trailing twelve months EPS of $7.53.

PE Ratio

Essex Property Trust has a trailing twelve months price to earnings ratio of 32.46. Meaning, the purchaser of the share is investing $32.46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.6%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 9.24 and the estimated forward annual dividend yield is 3.77%.

Volatility

Essex Property Trust’s last week, last month’s, and last quarter’s current intraday variation average was 0.74%, 0.58%, and 1.13%.

Essex Property Trust’s highest amplitude of average volatility was 0.74% (last week), 1.01% (last month), and 1.13% (last quarter).

More news about Essex Property Trust.

7. Illumina (ILMN) – Premarket: -0.57%

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

NASDAQ ended the session with Illumina dropping 1.27% to $188.07 on Tuesday while NASDAQ rose 0.19% to $14,058.87.

Earnings Per Share

As for profitability, Illumina has a trailing twelve months EPS of $-29.19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.02%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 96.5% and positive 35.3% for the next.

Volatility

Illumina’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.07%, a negative 0.36%, and a positive 1.93%.

Illumina’s highest amplitude of average volatility was 1.81% (last week), 1.70% (last month), and 1.93% (last quarter).

Earnings Before Interest, Taxes, Depreciation, and Amortization

Illumina’s EBITDA is -597.83.

Yearly Top and Bottom Value

Illumina’s stock is valued at $188.07 at 08:34 EST, way under its 52-week high of $248.87 and above its 52-week low of $179.75.

More news about Illumina.

8. Cronos Group (CRON) – Premarket: -0.54%

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

NASDAQ ended the session with Cronos Group falling 0.12% to $1.85 on Tuesday, after three successive sessions in a row of losses. NASDAQ jumped 0.19% to $14,058.87, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Cronos Group has a trailing twelve months EPS of $-0.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.69%.

Moving Average

Cronos Group’s value is higher than its 50-day moving average of $1.84 and way below its 200-day moving average of $2.31.

Yearly Top and Bottom Value

Cronos Group’s stock is valued at $1.85 at 08:34 EST, way under its 52-week high of $3.62 and way higher than its 52-week low of $1.66.

Revenue Growth

Year-on-year quarterly revenue growth declined by 19.5%, now sitting on 87.02M for the twelve trailing months.

More news about Cronos Group.

9. iShares MBS ETF (MBB) – Premarket: -0.48%

NASDAQ ended the session with iShares MBS ETF falling 0.12% to $93.06 on Tuesday, following the last session’s downward trend. NASDAQ jumped 0.19% to $14,058.87, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, iShares MBS ETF has a trailing twelve months EPS of $2.86.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, iShares MBS ETF’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for iShares MBS ETF is 1942780 which is 1.96% above its average volume of 1905320.

More news about iShares MBS ETF.

10. CNH Industrial (CNHI) – Premarket: -0.39%

CNH Industrial N.V., an equipment and services company, engages in the design, production, marketing, sale, and financing of agricultural and construction equipment in North America, Europe, the Middle East, Africa, South America, and the Asia Pacific. The company operates through three segments: Agriculture, Construction, and Financial Services. The Agriculture segment designs, manufactures, and distributes farm machinery and implements, including two-wheel and four-wheel drive tractors, crawler tractors, combines, grape and sugar cane harvesters, hay and forage equipment, planting and seeding equipment, soil preparation and cultivation implements, and material handling equipment. This segment sells its agricultural equipment under the New Holland Agriculture and Case IH brands. The Construction segment designs, manufactures, and distributes construction equipment comprising excavators, crawler dozers, graders, wheel loaders, backhoe loaders, skid steer loaders, and compact track loaders under the CASE Construction Equipment, New Holland Construction, and Eurocomach brands. The Financial Services segment offers retail note and lease financing to end-use customers for the purchase of new and used agricultural and construction equipment and components, as well as revolving charge account financing and other financial services. It also provides wholesale financing to CNH Industrial brand dealers and distributors; and trade receivables factoring services to CNH Industrial companies, as well as financial services to Iveco Group companies in the North America, South America, and Asia Pacific regions. The company was founded in 1842 and is headquartered in London, the United Kingdom.

NYSE ended the session with CNH Industrial rising 1.82% to $15.63 on Tuesday, following the last session’s upward trend. NYSE jumped 0.49% to $16,369.14, after five successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, CNH Industrial has a trailing twelve months EPS of $1.6.

PE Ratio

CNH Industrial has a trailing twelve months price to earnings ratio of 9.77. Meaning, the purchaser of the share is investing $9.77 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.4%.

More news about CNH Industrial.

Stay up to date with our premarket winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *